PCM
ELV icon

Prelude Capital Management’s Elevance Health ELV Stock Holding History

Prelude Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-25,000
Closed -$6.57M – 1862
2018
Q4 		$6.57M Hold
25,000
– – 0.44% 33
2018
Q3 		$6.85M Hold
25,000
– – 0.4% 39
2018
Q2 		$5.95M Buy
+25,000
New +$5.79M 0.38% 45

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Prelude Capital Management's ELV Position: Q1 2026 in Review

Prelude Capital Management reduced its Elevance Health (ELV) stake by 64% in Q1 2026, selling an estimated $1.03M and leaving 1,770 shares worth $518K. The position accounts for 0.04% of the portfolio, ranked #490.

Prelude Capital Management first reported a position in ELV in Q4 2013 and has held it in 27 quarters since. The position peaked at $1.8M in Q2 2022. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Prelude Capital Management held 1,770 shares of Elevance Health worth $518K as of Q1 2026.
  • Prelude Capital Management sold 3,148 Elevance Health shares in Q1 2026, an estimated $1.03M.
  • Elevance Health made up 0.04% of Prelude Capital Management's portfolio in Q1 2026, its #490 holding.
  • Prelude Capital Management first reported a position in Elevance Health in Q4 2013 and has held it in 27 quarters since.
  • Prelude Capital Management's Elevance Health position peaked at $1.8M in Q2 2022.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.